SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales declined to Rs. 9325.80 millions for the December 2021 quarter as compared to Rs. 12722.70 millions during the corresponding quarter last year.A big decline of -59.11% was reported for the quarter ended December 2021 to Rs. 1091.60  millions from Rs. 2669.60 millions of corresponding previous quarter.Operating profit for the quarter ended December 2021 decreased to 2226.10 millions as compared to 4233.10 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 9325.80 12722.70 -26.70 33293.80 33699.80 -1.20 47687.20 27973.40 70.47
Other Income 71.90 85.40 -15.81 192.60 216.00 -10.83 273.20 58.10 370.22
PBIDT 2226.10 4233.10 -47.41 9315.50 10690.20 -12.86 15371.90 5760.40 166.85
Interest 209.40 169.30 23.69 665.70 448.60 48.40 659.20 877.10 -24.84
PBDT 2016.70 4063.80 -50.37 8649.80 10241.60 -15.54 14712.70 4883.30 201.29
Depreciation 597.20 494.60 20.74 1745.40 1459.10 19.62 1966.40 1838.50 6.96
PBT 1419.50 3569.20 -60.23 6904.40 8782.50 -21.38 12746.30 3044.80 318.63
TAX 327.90 899.60 -63.55 1615.70 2149.20 -24.82 3185.20 374.30 750.98
Deferred Tax -48.70 21.40 -327.57 66.00 -87.20 -175.69 -164.60 -155.70 5.72
PAT 1091.60 2669.60 -59.11 5288.70 6633.30 -20.27 9561.10 2670.50 258.03
Equity 1074.70 1073.20 0.14 1074.70 1073.20 0.14 1073.20 1069.10 0.38
PBIDTM(%) 23.87 33.27 -28.26 27.98 31.72 -11.80 32.23 20.59 56.54

Laurus Labs Share Price

1229.45 23.00 (1.91%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×